logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
04/06/2025
Mexican President Lpez Obrador: Has not decided whether to attend the G7 summit.
Latest
2 m ago
China National Pharmaceutical Group Corporation: Subsidiary's Registration Certificate for Metoprolol Hydrochloride Tablets Approved
2 m ago
Crystal jewelry becomes "internet celebrities" with the help of e-commerce to boost China's crystal exports.
2 m ago
National Energy Administration: Build or retrofit a variety of virtual power plants according to local conditions.
3 m ago
Modern medicine: Azithromycin tablets and Diprophylline injections passing generic drug consistency evaluation.
3 m ago
Yaoxian Modern Announces that its wholly-owned subsidiary, China National Pharmaceutical Group Rongsheng Pharmaceutical Co., Ltd., has received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration for the approval of Azithromycin tablets and Theophylline injection through generic drug quality and efficacy consistency evaluation. Azithromycin tablets are used for infections caused by sensitive bacteria, with sales of 685 million yuan in 2024 in national public medical institutions and urban pharmacies. Theophylline injection is used for the treatment of bronchial asthma, with sales of 135 million yuan in 2024 in national public medical institutions. This consistency evaluation is conducive to product market expansion and sales.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.